These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 34479584
1. Impact of glycogen storage disease type I on adult daily life: a survey. Garbade SF, Ederer V, Burgard P, Wendel U, Spiekerkoetter U, Haas D, Grünert SC. Orphanet J Rare Dis; 2021 Sep 03; 16(1):371. PubMed ID: 34479584 [Abstract] [Full Text] [Related]
2. Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using 13C-glucose breath test. Turki A, Stockler S, Sirrs S, Duddy K, Ho G, Elango R. Mol Genet Metab Rep; 2023 Mar 03; 34():100955. PubMed ID: 36632325 [Abstract] [Full Text] [Related]
3. Nutrition therapy for hepatic glycogen storage diseases. Goldberg T, Slonim AE. J Am Diet Assoc; 1993 Dec 03; 93(12):1423-30. PubMed ID: 8245377 [Abstract] [Full Text] [Related]
4. Modifiable factors affecting renal preservation in type I glycogen storage disease after liver transplantation: a single-center propensity-match cohort study. Chan YC, Liu KM, Chen CL, Ong AD, Lin CC, Yong CC, Tsai PC, Lu LS, Wu JY. Orphanet J Rare Dis; 2021 Oct 11; 16(1):423. PubMed ID: 34635148 [Abstract] [Full Text] [Related]
5. Development of minimally invasive 13C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia. Turki A, Stockler S, Sirrs S, Salvarinova R, Ho G, Branov J, Rosen-Heath A, Bosdet T, Elango R. Mol Genet Metab Rep; 2022 Jun 11; 31():100880. PubMed ID: 35585965 [Abstract] [Full Text] [Related]
6. Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study. Shao YX, Liang CL, Su YY, Lin YT, Lu ZK, Lin RZ, Zhou ZZ, Zeng CH, Tao CY, Liu ZC, Zhang W, Liu L. Orphanet J Rare Dis; 2024 Apr 11; 19(1):155. PubMed ID: 38605407 [Abstract] [Full Text] [Related]
7. Continuous glucose monitoring in children with glycogen storage disease type I. Kasapkara ÇS, Cinasal Demir G, Hasanoğlu A, Tümer L. Eur J Clin Nutr; 2014 Jan 11; 68(1):101-5. PubMed ID: 24149443 [Abstract] [Full Text] [Related]
8. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Chou JY, Matern D, Mansfield BC, Chen YT. Curr Mol Med; 2002 Mar 11; 2(2):121-43. PubMed ID: 11949931 [Abstract] [Full Text] [Related]
9. Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis. Shah KK, O'Dell SD. J Hum Nutr Diet; 2013 Aug 11; 26(4):329-39. PubMed ID: 23294025 [Abstract] [Full Text] [Related]
10. Potential use of other starch sources in the treatment of glycogen storage disease type Ia - an in vitro study. Monteiro V, Colonetti K, Pagno CH, Schmidt HO, Sperb-Ludwig F, Oliveira BM, Poloni S, Rios AO, de Souza CFM, Schwartz IVD. Orphanet J Rare Dis; 2024 Jul 30; 19(1):283. PubMed ID: 39080776 [Abstract] [Full Text] [Related]
11. Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry. Kaiser N, Gautschi M, Bosanska L, Meienberg F, Baumgartner MR, Spinas GA, Hochuli M. Mol Genet Metab; 2019 Apr 30; 126(4):355-361. PubMed ID: 30846352 [Abstract] [Full Text] [Related]
12. Cornstarch requirements of the adult glycogen storage disease Ia population: A retrospective review. Dahlberg KR, Ferrecchia IA, Dambska-Williams M, Resler TE, Ross KM, Butler GL, Kuo CL, Ryan PT, Weinstein DA. J Inherit Metab Dis; 2020 Mar 30; 43(2):269-278. PubMed ID: 31415093 [Abstract] [Full Text] [Related]
13. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism. Lee PJ, Patel A, Hindmarsh PC, Mowat AP, Leonard JV. Clin Endocrinol (Oxf); 1995 Jun 30; 42(6):601-6. PubMed ID: 7634500 [Abstract] [Full Text] [Related]
14. Safety issues associated with dietary management in patients with hepatic glycogen storage disease. Steunenberg TAH, Peeks F, Hoogeveen IJ, Mitchell JJ, Mundy H, de Boer F, Lubout CMA, de Souza CF, Weinstein DA, Derks TGJ. Mol Genet Metab; 2018 Sep 30; 125(1-2):79-85. PubMed ID: 30037503 [Abstract] [Full Text] [Related]
15. [The application of continuous glucose monitoring in the management of hepatic glycogen storage disease]. Du CQ, Wei H, Zhang C, Zhang M, Hu MH, Hou L, Wu W, Liang Y, Luo XP. Zhonghua Er Ke Za Zhi; 2021 Jun 02; 59(6):452-458. PubMed ID: 34102817 [Abstract] [Full Text] [Related]
16. Glycogen storage disease type I: diagnosis and phenotype/genotype correlation. Matern D, Seydewitz HH, Bali D, Lang C, Chen YT. Eur J Pediatr; 2002 Oct 02; 161 Suppl 1():S10-9. PubMed ID: 12373566 [Abstract] [Full Text] [Related]
18. Utilization of cornstarch in glycogen storage disease type Ia. Bodamer OA, Feillet F, Lane RE, Lee PJ, Dixon MA, Halliday D, Leonard JV. Eur J Gastroenterol Hepatol; 2002 Nov 02; 14(11):1251-6. PubMed ID: 12439121 [Abstract] [Full Text] [Related]
19. Sleep and quality of life of patients with glycogen storage disease on standard and modified uncooked cornstarch. Rousseau-Nepton I, Huot C, Laforte D, Mok E, Fenyves D, Constantin E, Mitchell J. Mol Genet Metab; 2018 Mar 02; 123(3):326-330. PubMed ID: 29223626 [Abstract] [Full Text] [Related]
20. Asymptomatic critical hypoglycaemia: a dangerous presentation of glycogen storage disease type Ib in infancy. Bock DE, Rupar CA, Prasad C. Acta Paediatr; 2011 Sep 02; 100(9):e130-2. PubMed ID: 21352356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]